Bavarian Nordic INC.
Biotechnology pharmaceutical product discovery and development.
Based in DC
🤖
AI Overview
With $1.4M in lobbying spend across 29 quarterly filings, Bavarian Nordic INC. is a significant lobbying presence.
$1.4M
Total Lobbying Spend
29
Quarterly Filings
1
Lobbying Firms Used
4
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $90K |
| 2019 | $135K |
| 2020 | $180K |
| 2021 | $135K |
| 2022 | $270K |
| 2023 | $180K |
| 2024 | $225K |
| 2025 | $180K |
Lobbying Firms
EAST END GROUP, LLC
What They Lobby For
- General health care coverage and reimbursement for prescription drugs; Regulatory issues related to biodefense vaccine development and procurement; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; and the Food and Drug Administration legislative and regulatory issues.
- General health care coverage and reimbursement for prescription drugs; Regulatory issues related to biodefense vaccine development and procurement; H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; and the Food and Drug Administration legislative and regulatory issues.
- The re-authorization of the Pandemic and All-Hazards Preparedness Act. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill.
- Legislatives issues related to biodefense preparedness and response. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill.
- Legislatives issues related to biodefense preparedness and response. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill and Supplemental Appropriations.
- Legislatives issues related to biodefense preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill.
- Legislatives issues related to biodefense preparedness and response. Reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill and Supplemental Appropriations.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.